The antagonistic effects of temozolomide and trichostatin a combination on MGMT and DNA mismatch repair pathways in Glioblastoma
- 5 July 2023
- journal article
- research article
- Published by Springer Nature in Medical Oncology
- Vol. 40 (8) , 1-7
Abstract
Glioblastoma is the most aggressive and fatal form of brain cancer. Despite new advancements in treatment, the desired outcomes have not been achieved. Temozolomide (TMZ) is the first-choice treatment for the last two decades and has improved survival rates. Emerging studies have shown that targeting epigenetics in glioblastoma can be beneficial when combined with clinically used treatments. Trichostatin A (TSA), a histone deacetylase inhibitor, has anti-cancer properties in various cancers. No data concerning the TMZ and TSA relationship was shown previously in glioblastoma therefore, we aimed to determine the likely therapeutic effect of the TMZ and TSA combination in glioblastoma. The T98G and U-373 MG, glioblastoma cell lines, were used in this study. TMZ and TSA cytotoxicity and combination index were performed by MTT assay. The expression of DNA repair genes (MGMT, MLH-1, PMS2, MSH2 and MSH6) was detected using RT-PCR. One-way analysis of variance (ANOVA) was used for statistical analysis. Combination index calculations revealed antagonistic effects of TMZ and TSA in terms of cytotoxicity. Antagonistic effects were more apparent in the T98G cell line, which is expressing MGMT relatively higher. MGMT and DNA Mismatch Repair (MMR) genes were upregulated in the T98G cell line, whereas downregulated in the U373-MG cell lines under TMZ and TSA combination treatment. It is concluded that MGMT might be playing a more active part than MMR genes in TMZ resistance to TMZ and TSA antagonism. This is the first study elucidating the TMZ and TSA relationship in cancer cell lines.Keywords
Funding Information
- Yüzüncü Yil Üniversitesi (Yüzüncü Yil Üniversitesi)
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (1919B011802106)
This publication has 29 references indexed in Scilit:
- Minor Changes in Expression of the Mismatch Repair Protein MSH2 Exert a Major Impact on Glioblastoma Response to TemozolomideCancer Research, 2015
- Effects of temozolomide (TMZ) on the expression and interaction of heat shock proteins (HSPs) and DNA repair proteins in human malignant glioma cellsCell Stress and Chaperones, 2015
- DNA demethylation is superior to histone acetylation for reactivating cancer-associated genes in ovarian cancer cellsMolecular Medicine Reports, 2011
- Role of Histone Modifications and DNA Methylation in the Regulation of O6-Methylguanine-DNA Methyltransferase Gene Expression in Human Stomach Cancer CellsCancer Investigation, 2010
- MLH1 protects from resistance acquisition by the histone deacetylase inhibitor trichostatin A in colon tumor cellsInternational Journal of Oncology, 2009
- Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenograftsNeuro-Oncology, 2009
- Attenuated DNA Damage Repair by Trichostatin A through BRCA1 SuppressionRadiation Research, 2007
- Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination StudiesPharmacological Reviews, 2006
- Critical Role of Histone Methylation in Tumor Suppressor Gene Silencing in Colorectal CancerMolecular and Cellular Biology, 2003
- Regulation of the HumanO 6-Methylguanine-DNA Methyltransferase Gene by Transcriptional Coactivators cAMP Response Element-binding Protein-binding Protein and p300Journal of Biological Chemistry, 2000